Delivery Order SPE2DB24D1201-SPE2DB24FJBBG
Award Date
8/21/24
Potential Completion Date
8/22/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg to the Defense Logistics Agency (DLA). The contract, valued at $4,053.22, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This...
This federal contract award is for the delivery of 4,563,310,435 units of Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA), which is a defense agency. The contract was awarded on January 11, 2024, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $1,541.82. This is a delivery order contract with a firm fixed price, and the ultimate completion date is January 12, 2024. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,081.48 firm fixed-price delivery order is for the supply of 4,565,546,920 units of Tamsulosin Hydrochloride 0.4 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
This federal contract award is for the delivery of 1,000 units of the pharmaceutical drug Tamsulosin HCL 0.4 mg capsules to the Defense Logistics Agency (DLA). The $2,229.12 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies. The award does not have a set-aside designation, and the ultimate completion date is August 6, 2024....
This federal contract award is for the supply of 4,566,816,352 units of the drug Tamsulosin HCL 0.4 mg capsules, valued at $1,087.28, with a completion date of January 2, 2025. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. It is not designated with a set-aside requirement,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg. The $5,622.40 award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to support Department of Defense military treatment facilities...
This federal contract award is a delivery order valued at $1,443.94, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules, with a performance period ending on May 15, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and no subcontractors...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,618,995 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $8,489.68 and an Ultimate Completion Date of March 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,823,091 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $5,949.44 and an ultimate completion date of August 16, 2023. The contract was awarded on August 15, 2023 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
This federal contract award is for the delivery of Tamsulosin HCL 0.4 mg capsules (1,000 per order) to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $2,286.66 and is set to expire on September 21, 2023. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...